Tiotropium in chronic obstructive pulmonary disease - A review of clinical development

Medicine and Dentistry

• Tiotropium Bromide 100%
• Chronic Obstructive Pulmonary Disease 66%
• Muscarinic Antagonist 33%
• Drug Therapy 22%
• Inhalation 22%
• Treatment of Chronic Obstructive Pulmonary Disease 22%
• Lung 22%
• Monotherapy 11%
• Disease Exacerbation 11%
• Maintenance Therapy 11%
• Bronchodilating Agent 11%
• Development 11%
• Olodaterol 11%
• Endurance Training 11%
• Evaluation Study 11%
• Drug 11%
• Chemotherapeutic Agent 11%
• Airflow 11%
• Hyperinflation 11%
• Dry Powder Inhaler 11%
• Therapeutic Procedure 11%
• Health 11%
• Quality of Life 11%
• Inpatient 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Obstructive Lung Disease 66%
• Muscarinic Receptor Blocking Agent 33%
• Agonist 22%
• Controlled Clinical Trial 22%
• Placebo 22%
• Dry Powder Inhaler 11%
• Disease Exacerbation 11%
• Monotherapy 11%
• Dyspnea 11%
• Bronchodilating Agent 11%
• Drug 11%
• Tiotropium Bromide 11%
• Aerosol 11%
• Olodaterol 11%